Genomenon Overview

  • Founded
  • 2014

Founded

  • Status
  • Private

  • Employees
  • 68

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $20M

  • Investors
  • 25

Genomenon General Information

Description

Developer of genome interpretation software designed to improve cancer diagnosis and treatment. The company's software offers a set of diagnostic and discovery tools to identify disease-causing genomic variants and assists to treat cancer and other inheritable diseases, enabling physicians to improve patient outcomes.

Contact Information

Website
www.genomenon.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Biotechnology
Primary Office
  • 3135 South State Street
  • Suite 350 BR
  • Ann Arbor, MI 48108
  • United States
+1 (734) 000-0000

Genomenon Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomenon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series B) 23-Feb-2022 $20M 000.00 0000 Completed Generating Revenue
14. Grant 15-Feb-2022 00.000 000.00 Completed Generating Revenue
13. Later Stage VC (Series A) 00.00 000.00 000.00 Completed Generating Revenue
12. Secondary Transaction - Private 01-Aug-2021 000.00 Completed Generating Revenue
11. Later Stage VC (Series A) 16-Mar-2021 00.00 000.00 Completed Generating Revenue
10. Debt - PPP 07-Apr-2020 00.00 Completed Generating Revenue
9. Grant 01-May-2019 00000 00.00 Completed Generating Revenue
8. Later Stage VC 08-Jan-2019 00.00 00.00 Completed Generating Revenue
7. Early Stage VC (Series A) 07-Jul-2018 $1.25M $3.8M 00.000 Completed Generating Revenue
6. Grant 25-Apr-2017 $1.8M $2.55M Completed Generating Revenue
To view Genomenon’s complete valuation and funding history, request access »

Genomenon Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 1 1,303,131 $0.000100 $1.9 $1.9 1x $1.9 11.51%
Seed 1,590,190 $0.000100 $1.71 $1.71 1x $1.71 14.05%
To view Genomenon’s complete cap table history, request access »

Genomenon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genome interpretation software designed to improve cancer diagnosis and treatment. The company's software o
Discovery Tools (Healthcare)
Ann Arbor, MI
68 As of 2023
000.00
000 0000-00-00
00000000000 000.00

0000 0

r adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna al
000000000 00000 (000
Toronto, Canada
000 As of 0000
00000
00000000000 00000

000000

. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000000000000
Baltimore, MD
000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genomenon Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Deep Genomics Venture Capital-Backed Toronto, Canada 000 00000 00000000000 00000
00000000 000000 00 Formerly VC-backed Baltimore, MD 000 00000 000000&0 00000
0000000000 (000000 Formerly VC-backed New York, NY 00 000.00 000000&0 000.00
000000000 Private Equity-Backed Creve Coeur, MO 000 000.00 000000000000 000.00
0000000 00000000 Venture Capital-Backed Waltham, MA 000 00000 00000000000 00000
You’re viewing 5 of 29 competitors. Get the full list »

Genomenon Executive Team (10)

Name Title Board Seat Contact Info
Michael Klein Co-Chief Executive Officer & Board Member
Mark Kiel Ph.D Co-Founder, Co-Chief Executive Officer, Chief Scientific Officer & Board Member
Sean Kearney Chief Financial Officer
Samuel Globus Ph.D Chief Operating Officer
Steve Schwartz Co-Founder & Chief Technology Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Genomenon Board Members (8)

Name Representing Role Since
Brittnee Jones Genomenon Board Member 000 0000
Charlie Moret Invest Michigan Board Member 000 0000
David Gregorka Invest Michigan Board Member 000 0000
Mark Kiel Ph.D Genomenon Co-Founder, Co-Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000
Michael Klein Genomenon Co-Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Genomenon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genomenon Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Beringea Venture Capital Minority 000 0000 000000 0
P93 Ventures Venture Capital Minority 000 0000 000000 0
Spring Mountain Capital Growth/Expansion Minority 000 0000 000000 0
Small Business Innovation Research and Small Business Technology Transfer Programs Government 000 0000 000000 0
BroadOak Capital Partners Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 25 investors. Get the full list »

Genomenon Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 27-Jun-2023 0000000000 BPO/Outsource Services 0000000 0
To view Genomenon’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Genomenon Subsidiaries (1)

Company Name Industry Location Founded
000000 00000000 BPO/Outsource Services Cambridge, MA 0000
To view Genomenon’s complete subsidiaries history, request access »